Design and synthesis of novel quinazolin‐4(1
<i>H</i>
)‐one derivatives as potent and selective inhibitors targeting AKR1B1
作者:Zhongfei Han、Jiahui Li、Zilu Xu、Yu Su、Yihan Wang、Lili Zhuo、Jiaming Du、Changjin Zhu、Xin Hao
DOI:10.1002/ardp.202200577
日期:——
the treatment of diabetic complications. However, most of the developed small molecule inhibitors lack selectivity or suffer from low bioactivity. To address this limitation, a novel series of quinazolin-4(1H)-one derivatives as potent and selective inhibitors of AKR1B1 were designed and synthesized. Aldose reductase inhibitory activities of the novel compounds were characterized by IC50 values ranging
抑制醛糖还原酶 (AKR1B1) 是治疗糖尿病并发症的一个很有前途的选择。然而,大多数已开发的小分子抑制剂缺乏选择性或生物活性低。为了解决这一局限性,设计并合成了一系列新的喹唑啉-4(1 H )-酮衍生物作为 AKR1B1 的有效和选择性抑制剂。新型化合物的醛糖还原酶抑制活性的特征在于 IC 50值范围为 0.015 至 31.497 μM。还记录了这些衍生物显着增强的选择性,对接研究进一步支持了这一点。在这些抑制剂中,化合物5g表现出最高的抑制活性,选择性指数达到1190.8。结构-活性关系突出了 N1-乙酸和 N3-苄基在 quinazolin-4(1 H )-one 支架上具有吸电子取代基对于构建高效和选择性 AKR1B1 抑制剂的重要性。